GlaxoSmithKline to Implement Medidata Designer
Medidata Solutions announced that GlaxoSmithKline (GSK) has decided to implement Medidata Designer, a study design optimization solution, for its Clinical Research and Development organization. Using Designer, GSK can consistently design studies that meet key objectives and collect necessary data in a streamlined and efficient manner.
Medidata Designer drives study design quality with a CDISC-compliant data model that enforces the links across objectives, end points and procedures. This reusable metadata accelerates system setup, such as electronic data capture build, and automates the derivation of protocols and other key clinical deliverables. It improves compliance with standards, allows clinicians to focus on the science of clinical research and not on document management, and speeds study starts, shortening time to market for new therapies.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
